Serious adverse effects appear rare but remain possible until more comprehensive long-term studies are completed
AOD-9604 (Anti-Obesity Drug 9604) is a 16-amino-acid synthetic peptide based on residues 176-191 of the C-terminal region of human growth hormone, with the N-terminal phenylalanine replaced by tyrosine to improve stability
Frequency: Once per day, subcutaneous injection
GHK-Cu stimulates fibroblasts to produce collagen types I and III, glycosaminoglycans, and decorin
Furthermore, if you are seeking support in applying for funding, you can also do so with the help of TurboSBIR, which offers a winning combination of AI and expert support to help you apply in an easier, more compliant, and scalable manner
Go for walks, do easy strength work, and calm breathing after meals